Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 16, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Standard Biotools Inc.
| 26.38K |
—
|
—
| +33.64% | 104.79K |
Jun 14
| |||||||
Standard Biotools Inc.
| 30.91K |
—
|
—
| +65.08% | 78.42K |
Jun 15
| |||||||
Travere Therapeutics, Inc.
| -2.20K |
$21.51 | -$47,322.00 | -5.81% | 35.66K |
May 10 - May 11
|
Scheduled
| ||||||
Genasys Inc.
| 50K |
$1.33 | $66,500.00 | +21.34% | 284.31K |
Apr 27
| |||||||
Genasys Inc.
| 30K |
—
|
—
| +14.68% | 234.31K |
Mar 15
| |||||||
Genasys Inc.
| 6.28K |
$2.65 | $131.76 | +3.17% | 204.31K |
Feb 23
| |||||||
Travere Therapeutics, Inc.
| 8.6K |
$27.40 | -$33,921.20 | +29.41% | 37.85K |
Jan 31
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| -2.06K |
$24.98 | -$51,533.74 | -6.59% | 29.25K |
Jan 24
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
|
0
|
$27.40 | -$205,500.00 |
—
| 31.32K |
Jan 10 - Jan 11
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| 3.09K |
$17.12 | -$24,085.31 | +10.96% | 31.32K |
Aug 13 - Aug 17
| |||||||
Fluidigm Corp
| 10.34K |
—
|
—
| +27.83% | 47.5K |
May 25
| |||||||
Travere Therapeutics, Inc.
| -4.00K |
$19.30 | -$77,200.00 | -12.41% | 28.22K |
May 11 - May 12
|
Scheduled
| ||||||
Genasys Inc.
| 27.88K |
—
|
—
| +19.90% | 168.03K |
Mar 16
| |||||||
Genasys Inc.
| 14.54K |
$4.72 | -$64.97 | +9.35% | 170.14K |
Mar 10
| |||||||
Fluidigm Corp
| 9.8K |
—
|
—
| +35.83% | 37.16K |
Feb 20
| |||||||
Travere Therapeutics, Inc.
| -4.50K |
$31.50 | -$141,727.50 | -12.25% | 32.22K |
Feb 5 - Feb 8
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| 4.5K |
—
|
—
| +13.97% | 36.72K |
Feb 3
| |||||||
Travere Therapeutics, Inc.
| -3.63K |
$28.91 | -$104,798.75 | -10.11% | 32.22K |
Feb 3
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| 1.38K |
$30.75 | -$111,468.75 | +3.99% | 35.85K |
Jan 31 - Feb 2
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| 15K |
—
|
—
| +77.03% | 34.47K |
Jan 21
| |||||||
Travere Therapeutics, Inc.
|
0
|
$23.29 | -$174,675.00 |
—
| 19.47K |
Nov 23 - Nov 25
|
Scheduled
| ||||||
Travere Therapeutics, Inc.
| -7.50K |
$23.98 | -$179,812.50 | -27.81% | 19.47K |
Nov 16
|
Scheduled
| ||||||
Retrophin, Inc.
| 7.5K |
$23.61 | -$177,071.25 | +38.51% | 26.97K |
Nov 11 - Nov 13
|
Scheduled
| ||||||
Retrophin, Inc.
| -1.50K |
$18.48 | -$27,720.00 | -7.15% | 19.47K |
Sep 23
|
Scheduled
| ||||||
Retrophin, Inc.
| 1.5K |
$18.59 | -$27,885.00 | +7.70% | 20.97K |
Sep 18 - Sep 22
|
Scheduled
| ||||||
Fluidigm Corp
| 13.37K |
—
|
—
| +95.58% | 27.36K |
Jun 23
| |||||||
Retrophin, Inc.
| -3.03K |
$16.22 | -$49,088.23 | -13.45% | 19.47K |
May 11 - May 12
|
Scheduled
| ||||||
Retrophin, Inc.
| -4.00K |
$15.02 | -$60,080.00 | -15.09% | 22.5K |
Mar 10
|
Scheduled
| ||||||
Genasys Inc.
| 60K |
—
|
—
| +62.76% | 155.6K |
Mar 10 - Mar 12
| |||||||
Retrophin, Inc.
| 4K |
—
|
—
| +17.78% | 26.5K |
Mar 5
| |||||||
Retrophin, Inc.
| 9K |
—
|
—
| +66.67% | 22.5K |
Jan 31
| |||||||
Fluidigm Corp
| 3.99K |
—
|
—
| +39.87% | 13.99K |
Jun 3
| |||||||
Retrophin, Inc.
| -2.50K |
$18.25 | -$45,612.50 | -15.63% | 13.5K |
May 15 - May 16
|
Scheduled
| ||||||
Retrophin, Inc.
| 6K |
—
|
—
| +60.00% | 16K |
May 9
| |||||||
Lrad Corp
| 25K |
—
|
—
| +35.41% | 95.6K |
Mar 20
| |||||||
Lrad Corp
|
0
|
—
|
—
|
—
|
0
|
Mar 12
| |||||||
Lrad Corp
|
0
|
—
|
—
|
—
|
0
|
Mar 12
| |||||||
Retrophin, Inc.
| -2.03K |
$21.44 | -$43,587.46 | -16.90% | 10K |
Feb 11 - Feb 12
|
Scheduled
| ||||||
Retrophin, Inc.
| -7.50K |
$21.96 | -$164,664.70 | -38.40% | 12.03K |
Dec 20 - Dec 21
|
Scheduled
| ||||||
Retrophin, Inc.
| 7.5K |
—
|
—
| +62.33% | 19.53K |
Dec 18
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.